Revelation Biosciences released FY2024 semi-annual earnings on August 9, 2024 (EST), actual revenue USD 0, actual EPS USD 0

Brief Summary

In its semi-annual financial report for fiscal year 2024, Revelation Biosciences disclosed $0 in revenue, a net loss of $11,071,252, and an earnings per share (EPS) of $0.

Impact of The News

The financial results released by Revelation Biosciences for the first half of 2024 paint a clear picture of a company in the development stage, a common profile for clinical-stage biotechnology firms.